| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10238-018-0500-Y |
| P698 | PubMed publication ID | 29644482 |
| P50 | author | Michael Maes | Q30504745 |
| Andréa Name Colado Simão | Q88336514 | ||
| P2093 | author name string | Daniela Frizon Alfieri | |
| Edna Maria Vissoci Reiche | |||
| Isaias Dichi | |||
| Marcell Alysson Batisti Lozovoy | |||
| Bruna Miglioranza Scavuzzi | |||
| Neide Tomimura Costa | |||
| Bruno Alexandre Sekiguchi | |||
| Fabiano Aparecido de Medeiros | |||
| Marcelo Cândido de Sá | |||
| Tatiana Mayumi Veiga Iriyoda | |||
| Pâmela Lonardoni Micheletti | |||
| P2860 | cites work | Oxidation in rheumatoid arthritis. | Q21195671 |
| Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis | Q24797514 | ||
| The interplay between inflammation and metabolism in rheumatoid arthritis | Q26785751 | ||
| Molecular identification of a danger signal that alerts the immune system to dying cells | Q29619497 | ||
| Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant | Q33358818 | ||
| Chain breaking antioxidant status in rheumatoid arthritis: clinical and laboratory correlates | Q33563371 | ||
| Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases | Q33584105 | ||
| Leflunomide in the treatment of patients with early rheumatoid arthritis--results of a prospective non-interventional study | Q33956623 | ||
| Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. | Q34027578 | ||
| Reproductive factors and serum uric acid levels in females from the general population: the KORA F4 study | Q34199938 | ||
| Banting Lecture 1988. Role of insulin resistance in human disease. 1988. | Q34418764 | ||
| Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q34545044 | ||
| Pathogenesis of bone and cartilage destruction in rheumatoid arthritis | Q35158472 | ||
| Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures | Q35552648 | ||
| Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides | Q35766373 | ||
| Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis | Q35979054 | ||
| Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH). | Q35990760 | ||
| Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids | Q36203539 | ||
| Influence of Insulin Resistance and TNF-α on the Inflammatory Process, Oxidative Stress, and Disease Activity in Patients with Rheumatoid Arthritis | Q37000208 | ||
| Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study | Q37207061 | ||
| Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis | Q37350911 | ||
| Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing | Q37633519 | ||
| The active metabolite of leflunomide, A77 1726, attenuates inflammatory arthritis in mice with spontaneous arthritis via induction of heme oxygenase-1. | Q37638284 | ||
| Uric acid and hypertension: cause or effect? | Q37738112 | ||
| The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome | Q38047387 | ||
| Oxygen radicals, nitric oxide and human inflammatory joint disease | Q40458496 | ||
| Effective tumour necrosis factor-blocking therapy reduces reactive oxygen metabolite level in rheumatoid arthritis | Q42219877 | ||
| Status of oxidative stress in rheumatoid arthritis | Q43107164 | ||
| Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. | Q44438488 | ||
| Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. | Q44706589 | ||
| Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis | Q46436943 | ||
| Influence of uric acid and gamma-glutamyltransferase on total antioxidant capacity and oxidative stress in patients with metabolic syndrome | Q46579153 | ||
| Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis | Q46687305 | ||
| Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells | Q46776017 | ||
| Nitric oxide availability as a marker of oxidative stress | Q46824462 | ||
| Assessment of ischemia-modified albumin levels in patients with rheumatoid arthritis. | Q46867303 | ||
| Identification of clinical parameters associated with serum oxidative stress in patients with rheumatoid arthritis | Q46914146 | ||
| Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. | Q50957777 | ||
| Advanced oxidation protein products are more related to metabolic syndrome components than biomarkers of lipid peroxidation. | Q51298846 | ||
| Infliximab is equivalently suppressing oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis. | Q51364675 | ||
| The hypouricemiant effect of leflunomide. | Q54513719 | ||
| Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis | Q55067101 | ||
| 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative | Q56506042 | ||
| Influence of leflunomide on renal handling of urate and phosphate in patients with rheumatoid arthritis | Q57076798 | ||
| Nitric oxide is a mediator of apoptosis in the rheumatoid joint | Q57534159 | ||
| Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans | Q63866263 | ||
| Hydroperoxide-initiated chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscle | Q67915230 | ||
| Rheumatoid arthritis | Q68567938 | ||
| An experimental model for hydrogen peroxide-induced tissue damage. Effects of a single inflammatory mediator on (peri)articular tissues | Q69506389 | ||
| Advanced oxidation protein products as a novel marker of oxidative stress in uremia | Q71324551 | ||
| Increased nitric oxide levels in patients with rheumatoid arthritis | Q71707607 | ||
| Oxidative stress in blood of HIV infected patients | Q71820673 | ||
| Oxidative damage to proteins: spectrophotometric method for carbonyl assay | Q72024490 | ||
| Levels of plasma lipid peroxide products and antioxidant status in rheumatoid arthritis | Q73321276 | ||
| Semiautomated measurement of nitrate in biological fluids | Q74339100 | ||
| Association of serum uric acid with cardiovascular disease in rheumatoid arthritis | Q80651977 | ||
| Etanercept reduces the oxidative stress marker levels in patients with rheumatoid arthritis | Q80695386 | ||
| Uric acid and cardiovascular risk in rheumatoid arthritis | Q82655937 | ||
| Paraoxonase and arylesterase levels in rheumatoid arthritis | Q83208416 | ||
| No impact of serum uric acid on the outcome of recent-onset arthritis | Q83729866 | ||
| Serum protein oxidation in patients with rheumatoid arthritis and effects of infliximab therapy | Q83823925 | ||
| Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus | Q84669486 | ||
| The onset of lipid peroxidation in rheumatoid arthritis: consequences and monitoring | Q87075616 | ||
| Plasma glutathione peroxidase (GSH-Px) concentration is elevated in rheumatoid arthritis: a case-control study | Q87376514 | ||
| Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide | Q87534867 | ||
| Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis | Q89083185 | ||
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| metabolic syndrome | Q657193 | ||
| P304 | page(s) | 363-372 | |
| P577 | publication date | 2018-04-11 | |
| P1433 | published in | Clinical and Experimental Medicine | Q15753118 |
| P1476 | title | Metabolic syndrome and the decreased levels of uric acid by leflunomide favor redox imbalance in patients with rheumatoid arthritis | |
| P478 | volume | 18 |
| Q89669659 | Spectrum and prognosis of renal histopathological lesions in 56 Chinese patients with rheumatoid arthritis with renal involvement | cites work | P2860 |
Search more.